| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA804847 | F | Phosphorylation by uridine/cytidine kinase(UCK) from mouse sarcoma -180 ascites cells was measured. | Mus musculus | 9 | ALA1131043 | cell-based format | Scientific Literature | |
| 2. | ALA803894 | F | Phosphorylation by uridine/cytidine kinase(UCK) from mouse sarcoma -180 ascites cells was measured. | Mus musculus | 1 | ALA1131043 | cell-based format | Scientific Literature | |
| 3. | ALA803895 | F | Cytotoxicity against sarcoma -180 cells was measured by uridine/cytidine kinase(UCK) phosphorylation. | Mus musculus | 8 | ALA1131043 | cell-based format | Scientific Literature | |
| 4. | ALA801395 | F | Growth inhibition of cultured Sarcoma 180 cells after 48-h exposure to compound at 1.6 x 10E-8 M/mL in trail 1 | Mus musculus | 1 | ALA1121729 | cell-based format | Scientific Literature | |
| 5. | ALA801396 | F | Growth inhibition of cultured Sarcoma 180 cells after 48-h exposure to compound at 1.6 x 10E-8 M/mL in trail 2 | Mus musculus | 1 | ALA1121729 | cell-based format | Scientific Literature | |
| 6. | ALA801397 | F | Growth inhibition of cultured Sarcoma cells after 48-h exposure to compound at 4 x 10E-9 M/mL in trail 1 | Mus musculus | 1 | ALA1121729 | cell-based format | Scientific Literature | |
| 7. | ALA801398 | F | Growth inhibition of cultured Sarcoma cells after 48-h exposure to compound at 4 x 10E-9 M/mL in trail 2 | Mus musculus | 1 | ALA1121729 | cell-based format | Scientific Literature | |
| 8. | ALA801399 | F | Median survival time of sarcoma 180 cell line after a dose of 10 mg/kg administered intraperitoneally on Q01Dx01 treatment schedule | Mus musculus | 1 | ALA1122504 | organism-based format | Scientific Literature | |
| 9. | ALA801400 | F | Median survival time of sarcoma 180 cell line after a dose of 20 mg/kg administered intraperitoneally on Q01Dx01 treatment schedule | Mus musculus | 1 | ALA1122504 | organism-based format | Scientific Literature | |
| 10. | ALA801401 | F | Antitumor activity expressed as T/C at an intravenous dose of 0.10 mg/kg in mice implanted subcutaneously with murine sarcoma 180 cells. | Mus musculus | 1 | ALA1129161 | organism-based format | Scientific Literature | |
| 11. | ALA804115 | F | Antitumor activity expressed as T/C at an intravenous dose of 0.13 mg/kg in mice implanted subcutaneously with murine sarcoma 180 cells. | Mus musculus | 1 | ALA1129161 | organism-based format | Scientific Literature | |
| 12. | ALA804116 | F | Antitumor activity expressed as T/C at an intravenous dose of 0.13 mg/kg in mice implanted subcutaneously with murine sarcoma 180 cells; Not tested | Mus musculus | 1 | ALA1129161 | organism-based format | Scientific Literature | |
| 13. | ALA804117 | F | Antitumor activity expressed as T/C at an intravenous dose of 1.0 mg/kg in mice implanted subcutaneously with murine sarcoma 180 cells. | Mus musculus | 1 | ALA1129161 | organism-based format | Scientific Literature | |
| 14. | ALA804118 | F | Antitumor activity expressed as T/C at an intravenous dose of 8.0 mg/kg in mice implanted subcutaneously with murine sarcoma 180 cells. | Mus musculus | 1 | ALA1129161 | organism-based format | Scientific Literature | |
| 15. | ALA804119 | F | MST of treated animal over control when administered at a dose of 10 mg/kg intraperitoneally on Q01Dx01 treatment schedule in sarcoma 180 cell lines | Mus musculus | 1 | ALA1122504 | organism-based format | Scientific Literature | |
| 16. | ALA804120 | F | MST of treated animal over control when administered at a dose of 20 mg/kg intraperitoneally on Q01Dx01 treatment schedule in sarcoma 180 cell lines | Mus musculus | 1 | ALA1122504 | organism-based format | Scientific Literature | |
| 17. | ALA804121 | F | Number of survivors of sarcoma 180 cell line on day 5/ number of treated mice at a dose of 1 ip injection of 10 mg/kg on Q01Dx01 treatment schedule; 10/10 | Mus musculus | 1 | ALA1122504 | organism-based format | Scientific Literature | |
| 18. | ALA801992 | F | Number of survivors of sarcoma 180 cell line on day 5/ number of treated mice at a dose of 1 ip injection of 20 mg/kg on Q01Dx01 treatment schedule; 10/10 | Mus musculus | 1 | ALA1122504 | organism-based format | Scientific Literature | |
| 19. | ALA802004 | F | Percent reduction against sarcoma 180J tumor growth in mice when administered intraperitoneally at dose 100 mg/kg | Mus musculus | 3 | ALA1121487 | organism-based format | Scientific Literature | |
| 20. | ALA802005 | F | Percent reduction against sarcoma 180J tumor growth in mice when administered intraperitoneally at dose 200 mg/kg | Mus musculus | 6 | ALA1121487 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!